Status:

RECRUITING

Xiangya Cardiopulmonary Health and Disease Cohort

Lead Sponsor:

Xiangya Hospital of Central South University

Conditions:

Respiratory Function Tests,Heart Function Tests

Cardiopulmonary Function

Eligibility:

All Genders

Brief Summary

Xiangya Cardiopulmonary Health and Disease Cohort (XY-CPHDC) is a non-intervention study grounded in real-world data. It is designed as a bidrectional clinical cohort combined retrospective and prospe...

Detailed Description

1.2.1 Study objective 1. Construct a cardiopulmonary holistic assessment cohort covering the full range of resting-exercise-sleep scenarios and encompassing non-cardiopulmonary disease-- cardiopulmon...

Eligibility Criteria

Inclusion

  • I1 Inclusion and exclusion criteria for retrospective cohorts 1) Inclusion criteria:
  • Patients were either treated or hospitalized in the physical examination center, outpatient and emergency clinic in the Xiangya Hospital of Central South University from January 2010 to April 2025.
  • Completion of cardiac function (e.g., echocardiography) and pulmonary function (e.g., pulmonary function test) assessment, with an interval of no more than 1 year between the two.
  • Those who had complete clinical diagnostic and therapeutic information (e.g., medical history, medication records, laboratory test results, imaging reports) except for the cardiopulmonary function test report.
  • 2)Exclusion criteria
  • Patients with complete loss of cardiopulmonary function test reports or key data (e.g., VO2peak, FEV1/FVC, LVEF).
  • Patients with loss of key clinical diagnostic and treatment data (e.g., medical history, medication records, laboratory test results).
  • 1.2 Inclusion and exclusion criteria for prospective cohort
  • 1)Inclusion criteria
  • Patients who have been included in the retrospective cohort.
  • Voluntarily signed informed consent form to participate in long-term follow-up for ≥3 years.
  • Able to complete the baseline assessment of the prospective cohort (including cardiopulmonary function retesting, questionnaires, etc.).
  • Stable conditions for follow-up (e.g., living in the local area, available valid contact information, no plans to move in the short term or go out for a long period of time).
  • 2\) Exclusion Criteria.
  • Patients who have been excluded from the retrospective cohort or for whom key data are missing.
  • With severe cognitive impairment, psychiatric disease or verbal communication disorder, unable to cooperate with follow-up and data collection.
  • Expected survival time \<3 years (e.g., advanced malignancy, end-stage cardiopulmonary failure, etc.).
  • Incomplete cardiopulmonary function or other clinical data during the baseline assessment.
  • Those who plan to participate in other interventional clinical trials that may interfere with the assessment of cardiopulmonary function.

Exclusion

    Key Trial Info

    Start Date :

    June 1 2025

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2035

    Estimated Enrollment :

    30000 Patients enrolled

    Trial Details

    Trial ID

    NCT06972784

    Start Date

    June 1 2025

    End Date

    December 1 2035

    Last Update

    July 2 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Xiangya Hospital, Central South University Affiliated

    Changsha, Hunan, China, 457500

    Xiangya Cardiopulmonary Health and Disease Cohort | DecenTrialz